As of Oct 21
| -0.07 / -3.45%|
The 1 analysts offering 12-month price forecasts for CounterPath Corp have a median target of 3.41, with a high estimate of 3.41 and a low estimate of 3.41. The median estimate represents a +74.07% increase from the last price of 1.96.
The current consensus among 1 polled investment analysts is to Outperform stock in CounterPath Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.